Sepsis is a major cause of mortality during the neutropenic phase after intensive cytotoxic
therapies for malignancies. Improved management of sepsis during neutropenia may …

Sepsis and septic shock are major causes of mortality during chemotherapy-induced
neutropenia for malignancies requiring urgent treatment. Thus, awareness of the presenting …

Sepsis is a leading cause of mortality in neutropenic cancer patients. Early initiation of
effective causative therapy as well as intensive adjunctive therapy is mandatory to improve …

Background Neutropenic sepsis (NS) is a common and predictable complication of bone
marrow disorders and cytotoxic chemotherapy, with an estimated incidence of 70–100 …

Dear Editor, Neutropenic cancer patients are at high risk of sepsis [1]. The delay and
adequacy of antimicrobial treatment are likely to influence the outcomes of such patients …

Background In severe sepsis, guidelines recommend de-escalating the empirical
antimicrobial treatment as soon as the microbiological results are available. We aimed to …

Objective: To determine whether the survival gains achieved in critically ill cancer patients in
recent years exist in the subset with neutropenia and severe sepsis or septic shock. Design …

The management of patients with sepsis, severe sepsis, or septic shock requires an
integrated approach combining the use of rigorous diagnostic measures and the rapid …

Neutropenic sepsis is a potentially fatal complication of treatment for cancer, with mortality
rates of 2-21%. 1 An investigation by the National Confidential Enquiry into Patient Outcome …

Severe sepsis defined as infection-induced organ dysfunction or hypoperfusion
abnormalities predispose to septic shock and increased mortality in neutropenic setting. We …